Dr. Arie P. Dosoretz, MD

Dr. Dosoretz practices at Advocate Radiation Oncology in Port Charlotte, Florida.

Dr. Dosoretz's NPI, 1720303589, was assigned on April 5, 2010. Dr. Dosoretz graduated from Perelman School of Medicine - Philadelphia in 2010. Dr. Dosoretz holds Florida license ME124597.

Dr. Dosoretz's primary practice is Advocate Radiation Oncology, at 3080 Harbor Blvd, Port Charlotte, FL 33952 in Charlotte County. The practice phone is (941) 883-2199.

Dr. Dosoretz's primary practice is Advocate Radiation Oncology in Port Charlotte, Florida. Dr. Dosoretz is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Dosoretz to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dosoretz practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Dosoretz's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dosoretz is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Dosoretz's licenses on file in 13 states: Florida, Georgia, South Carolina, North Carolina, Michigan, Oregon, California, Maryland, Rhode Island, West Virginia, Massachusetts, Nevada and Washington.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Dosoretz treats.

CMS data shows 3,422 Medicare services from Dr. Dosoretz across 24 procedure codes in 2024, for 444 Medicare patients. Medicare paid $587,454 for them. Every service was in an office.

CMS counts 444 Medicare patients who saw Dr. Dosoretz in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dosoretz's median patient age at 74, with 33% women.

In 2021, Dr. Dosoretz wrote 25 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $148 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Dosoretz for performance year 2024, reported as part of a group. Dr. Dosoretz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dosoretz as offering telehealth.

Dmand AI links 19 papers to Dr. Dosoretz, published from 2011 to 2022. 2016 was the busiest year, with 4. The most frequent topics are Medicare, Radiation Oncology and Radiosurgery. Dr. Dosoretz has published most often in Int J Radiat Oncol Biol Phys. Dr. Dosoretz's most frequent co-authors are Benjamin Paul Falit, MD, Cary E. Gross, MD and Julian C. Hong, MD, MS.

CMS Open Payments shows 84 general payments to Dr. Dosoretz from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 26% of the total. Varian Medical Systems, Inc. paid the most, $4,267.

Dr. Dosoretz graduated from Perelman School of Medicine - Philadelphia in 2010.

Dr. Dosoretz is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.